[A clinico-laboratory assessment of the efficacy of an Augmentin suspension in treating children with suppurative-inflammatory diseases caused by opportunistic bacteria].
Augmentin suspension (amoxycillin+clavulanic acid) was estimated in clinico-laboratory studies with respect to children suffering from pyoinflammatory diseases of various localization and its high efficacy was shown. Good and satisfactory results were recorded in 96.3 per cent of the cases in the treatment (monotherapy) and afterwards in the patients, adverse reactions such as nausea and vomiting being recorded only in 1 patient. The therapy with augmentin led to normalization of the microflora of the upper respiratory tract mucosa and a 1.5-fold increase in the neutrophil engulfment index.
Savitskaia
K I
KI
Nekhorosheva
A G
AG
Skala
L Z
LZ
Nasonov
V N
VN
Solodilova
O E
OE
Shanina
A G
AG
Dutova
E N
EN
D000658:Amoxicillin / Q000008:administration & dosage* / Q000494:pharmacology; D019980:Amoxicillin-Potassium Clavulanate Combination; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D002969:Clavulanic Acids / Q000008:administration & dosage* / Q000494:pharmacology; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000494:pharmacology; D004361:Drug Tolerance; D005490:Focal Infection / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008826:Microbial Sensitivity Tests; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D013535:Suspensions
D002969:Clavulanic Acids; D013535:Suspensions; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin
Kliniko-laboratornaia otsenka éffektivnosti Augmentin-suspenzii pri lechenii deteĭ s gnoĭno-vospalitel'nymi zabolevaniiami, vyzvannymi uslovno-patogennymi bakteriiami.